Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension

American Journal of Hypertension

Volumn 10, Issue 4 I, 1997, Pages 379-388

  Baños, Guadalupe ^a   Carvajal, Karla ^a   Cardoso, Guillermo ^a   Zamora, José ^a   Franco, Martha ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

glucose; hypertension; hypertriglyceridemia; risk factors; very low density lipoproteins; Wistar rat

Indexed keywords

ACETYLCHOLINE; GLUCOSE; INSULIN; NORADRENALIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PROTEINS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030943353     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00400-1     Document Type: Article

References (36)

1. Krzesinski JM, Carlier PG, Rorive GL: Interrelationship of hypertension, plasma lipids and atherosclerosis. Drugs 1988;36 (suppl 2):18-26.
2. Assman G, Schulte H: The prospective cardiovascular Münster study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol 1987;59:9G-17G.
3. Schwandt P: The triglyceride controversy: a review of the data. Eur Heart J 1990;11 (suppl H):38-43.
4. Castelli WP: Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992;70:3H-9H.
5. Gianturco SH, Eskin SG, Navarro LT, et al: Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. Biochim Biophys Acta 1980;618:143-152.
6. Gianturco SH, Gotto AM, Hwang S-LC, et al: Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem 1983;258:4526-4533.
7. Gianturco SH, Bradley WA: Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia. Sem Thromb Haemost 1988;14:165-169.
8. Blum CB, Aron L, Sciacca R: Radioimmunoassay studies of human apolipoprotein E. J Clin Invest 1980; 66:1240-1250.
9. Eisenberg S: Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am Heart J 1987;113:555-561.
10. McNamara JR, Jenner JL, Li Z, et al: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arteriosckr Thromb 1992: 12:1284-1290.
11. Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994;5:339-349.
12. Austin MA: Genetics of low-density lipoprotein subclasses. Curr Opin Lipidol 1993;4:125-132.
13. Hwang I-S, Ho H, Huffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512-516.
14. Reaven GM, Ho H: Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens 1991,4:610-614.
15. Vrána A, Kazdová L: The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplant Proc 1990;22:2579.
16. Meehan WP, Buchanan TA, Hsueh W: Chronic insulin administration elevates blood pressure in rats. Hypertension 1994;23(part 2):1012-1017.
17. Touyz RM, Schiffrin EL: Insulin-induced Ca 2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension 1994; 23(part 2):931-935.
18. Katayama S, Abe M, Kashiwabara H, et al: Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. Hypertension 1994;23(part 2):1071-1074.
19. Nägele U, Hägele EO, Sauer G, et al: Reagent for the enzymatic determination of serum triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22:165-174.
20. Siedel J, Hagele DE, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29(6):1075-1080.
21. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28 (6):1379-1388.
22. Friedewald WT, Levy RI, Frederickspn DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Sheehan DC: Nuclear and cytoplasmic stains (Chapter 8), in Sheehan DC, Hrapchak BB (eds): Theory and Practice of Histotechnology. CV Mosby, St. Louis, 1980, pp 137-158.
24. Villalobos R, Castillo C, Hong E: Pelanserine inhibition of serotonin-induced phosphatidyl inositol turnover and contraction in rabbit aorta. Drug Devel 1991; 23:281-287.
25. Martínez FJ, Rizza RA, Romero JC: High fructose feeding, insulin resistance, hyperinsulinism and hypertension in normal mongrel dogs. Hypertension 1994; 23:456-463.
26. Pérez-Vizcaíno F, Navarro J, Tamargo J, et al: Endothelium-dependent responses in fructose-induced hypertension (abst). J Hypertens 1993;11(suppl 5):S468.
27. Brands MW, Garrity CA, Holman MG, et al: High-fructose diet does not raise 24-hour mean arterial pressure in rats. Am J Hypertens 1994;7(1):104-109
28. Takahashi M, Yui Y, Yasumoto H, et al: Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol 1990;258:H1-H8.
29. Weidmann P, de Courten M, Bohlen L: Insulin resistance, hyperinsulinemia and hypertension. J Hypertens 1993;11(suppl 5):S27-S38.
30. Reaven GM, Ho H, Hoffmann BB: Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989;14:117-120.
31. Kahn AM, Seidel CL, Allen JC, et al: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993;22:735-742.
32. 2-adrenergic pathway in humans. Hypertension 1994;24:429-438.
33. Gros R, Borkowski KR, Feldman RD: Human insulin-mediated enhancement of vascular β-adrenergic responsiveness. Hypertension 1994;23:551-555.
34. Yokoyama M, Henry PD: Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res 1979;45:479-486.
35. Mangin EL Jr, Kugiyama K, Nguy JH, et al: Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res 1993;72:161-166.
36. Berliner JA, Haberland ME: The role of oxidized low-density lipoprotein in atherogenesis. Curr Opin Lipidol 1993;4:373-381.